The Role of Midkine in the Inflammatory Process and Its Correlation with Other Inflammatory Markers in Renal Transplant Recipients
- 1 June 2016
- journal article
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 39 (6) , 277-281
Abstract
Background: Midkine (MK), which is expressed in the proximal tubular epithelial cells of the kidney, is thought to have a role in the pathophysiology of inflammation-related renal diseases. Both immunological and nonimmunological mechanisms may affect renal functions negatively during the early and late post-transplantation periods. We aimed in our study to evaluate the relationship of MK with clinical findings and inflammatory markers, including high sensitivity C-reactive protein (hs-CRP), interleukin (IL-6) and tumor necrosis factor (TNF-α) in the pretransplant and post-transplant period. Methods: Forty-one consecutive patients transplanted from living related donors were included in this prospective observational study. All patients received the same immunosuppressive treatment protocol. MK, hsCRP, IL-6 and TNF-α levels were measured before and 2 months after renal transplantation. Results: Pretransplant MK levels correlated positively with hsCRP (r = 0.41, p = 0.004) and IL-6 (r = 0.58, p<0.001). The mean post-transplant MK level was found to be higher than the pretransplant level (143 ± 350 pg/mL, 2792 ± 4235 pg/mL respectively, p = <0.001), while the mean hsCRP, IL-6 and TNF-α levels did not change significantly. Post-transplant IL-6 correlated significantly with MK (r = 0.388, p = 0.012), hsCRP (r = 0.41, p = 0.007) and TNF-α (r = 0.348, p = 0.026). There was no significant correlation between clinical findings and inflammatory markers. Conclusions: MK may be a good inflammatory marker in renal transplant recipients as in other inflammatory diseases. Moreover, it seems that it is not affected by factors other than inflammation during the post-transplantation period.Keywords
This publication has 24 references indexed in Scilit:
- Prolonged cold ischemia accelerates cellular and humoral chronic rejection in a rat model of kidney allotransplantationTransplant International, 2012
- Midkine and the kidney: health and diseasesNephrology Dialysis Transplantation, 2011
- Circulating midkine in Crohnʼs disease: Clinical implicationsInflammatory Bowel Diseases, 2010
- The growth factor midkine regulates the renin-angiotensin system in miceJournal of Clinical Investigation, 2009
- Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathyLaboratory Investigation, 2007
- Midkine Plays a Protective Role Against Cardiac Ischemia/Reperfusion Injury Through a Reduction of Apoptotic ReactionCirculation, 2006
- Serum Albumin, C-Reactive Protein, Interleukin 6, and Fetuin A as Predictors of Malnutrition, Cardiovascular Disease, and Mortality in Patients With ESRDAmerican Journal of Kidney Diseases, 2006
- Identification of midkine as a mediator for intercellular transfer of drug resistanceOncogene, 2005
- Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusionKidney International, 2005
- Midkine, a heparin‐binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritisArthritis & Rheumatism, 2004